Table 1.
Variables | Sample size, n (%) |
---|---|
A | |
Total patients | 41 (100.0) |
Disease | |
NPC | 29 (70.7) |
OSCC | 12 (29.3) |
HLA type | |
A2 | 20 (48.8) |
Non A2 | 21 (51.2) |
B | |
Disease | |
NPC | 16 (80.0) |
OSCC | 4 (20.0) |
Age (median, 48.5; range, 30–67) | |
≤ 40 | 3 (15.0) |
> 40 | 17 (85.0) |
Ethnicity | |
Chinese | 16 (80.0) |
Malay | 2 (10.0) |
Indian | 2 (10.0) |
Gender | |
Male | 17 (85.0) |
Female | 3 (15.0) |
Overall staging | |
Early stage (Stage I and II) | 4 (20.0) |
Late stage (Stage III and IV) | 16 (80.0) |